Iguratimod suppresses volume-sensitive outwardly rectifying anion channels via arachidonic acid accumulation
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2026.178682 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Takahiro Shimizu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. Electronic address: taksh…. Hauptthemen laut MEDLINE: Arachidonic Acid, Chromones, Chloride Channels, Sulfonamides. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Iguratimod, an anti-rheumatic agent, is known to suppress the production of inflammatory cytokines and inhibit B-cell proliferation. Recent studies have implicated volume-sensitive outwardly rectifying (VSOR) Cl − channels in the regulation of immune responses. In this study, we investigated whether iguratimod modulates VSOR Cl − currents using whole-cell patch-clamp recordings in human embryonic kidney 293T cells. Iguratimod inhibited hypotonicity-induced VSOR Cl − currents in a concentration-dependent manner. Notably, celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, also significantly suppressed these currents. Furthermore, pyrrophenone, a phospholipase A 2 inhibitor, attenuated the inhibitory effect of iguratimod on VSOR Cl − currents. Under hypotonic conditions, the levels of free arachidonic acid were significantly elevated in the presence of iguratimod and celecoxib. These findings suggest that iguratimod increases free arachidonic acid levels by inhibiting COX-2 during osmotic cell swelling, thereby suppressing VSOR Cl − channel activity. This suppression of VSOR Cl − channel activity may present one of the mechanisms through which iguratimod exerts its anti-inflammatory effects in rheumatic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. Electronic address: takshimi@pha.u-toyama.ac.jp.
- Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
- Division of Nutritional Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shimizu, T., Sumiyoshi, S., Fujita, K., Fujii, T., Toba, T., Watanabe, S., & Sakai, H. (2026). Iguratimod suppresses volume-sensitive outwardly rectifying anion channels via arachidonic acid accumulation. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.178682
Vancouver
Shimizu T, Sumiyoshi S, Fujita K, Fujii T, Toba T, Watanabe S, et al. Iguratimod suppresses volume-sensitive outwardly rectifying anion channels via arachidonic acid accumulation. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2026.178682
BibTeX
@article{Shimizu2026,
author = {Shimizu, Takahiro and Sumiyoshi, Shiho and Fujita, Kyosuke and Fujii, Takuto and Toba, Toshihiro and Watanabe, Shiro and Sakai, Hideki},
title = {Iguratimod suppresses volume-sensitive outwardly rectifying anion channels via arachidonic acid accumulation},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2026.178682}
}
EUVIMED